US45784P1012
US45784P1012
Insulet Corporation
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 2.708.100.000 | 2.071.600.000 | 30.7% |
| Cost of Revenue | 768.200.000 | 625.900.000 | 22.7% |
| Gross Profit | 1.939.900.000 | 1.445.700.000 | 34.2% |
| 1.466.100.000 | 1.136.800.000 | 29.0% | |
| Operating Income | 473.800.000 | 308.900.000 | 53.4% |
| Pretax Income | 339.500.000 | 300.200.000 | 13.1% |
| Net Income Common Stockholders | 247.100.000 | 418.300.000 | 40.9% |
| -- | -- | -- | |
| -- | -- | -- |